These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16091003)

  • 21. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
    Gao HD; Sun JZ; Bi DS; Ma R
    Ai Zheng; 2003 Apr; 22(4):376-9. PubMed ID: 12703992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines.
    Pihie AH; Stanslas J; Din LB
    Anticancer Res; 1998; 18(3A):1739-43. PubMed ID: 9673398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture.
    Jain PT; Pento JT; Magarian RA
    Anticancer Res; 1992; 12(3):585-90. PubMed ID: 1622114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME; Katzenellenbogen BS
    Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell line MCF-7.
    Butler WB; Fontana JA
    Cancer Res; 1992 Nov; 52(22):6164-7. PubMed ID: 1423259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].
    Bachmann-Moisson N; Barberi-Heyob M; Merlin JL; Ledrich ML; Batt AM; Guillemin F
    Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR; Murphy LC; Hall RE; Sutherland RL
    Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination.
    Guthrie N; Gapor A; Chambers AF; Carroll KK
    J Nutr; 1997 Mar; 127(3):544S-548S. PubMed ID: 9082043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin E and breast cancer: a review.
    Kimmick GG; Bell RA; Bostick RM
    Nutr Cancer; 1997; 27(2):109-17. PubMed ID: 9121936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genistein inhibits tamoxifen effects on cell proliferation and cell cycle arrest in T47D breast cancer cells.
    Jones JL; Daley BJ; Enderson BL; Zhou JR; Karlstad MD
    Am Surg; 2002 Jun; 68(6):575-7; discussion 577-8. PubMed ID: 12079141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.
    Krishnan AV; Swami S; Feldman D
    Steroids; 2012 Sep; 77(11):1107-12. PubMed ID: 22801352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids.
    Verma SP; Goldin BR; Lin PS
    Environ Health Perspect; 1998 Dec; 106(12):807-12. PubMed ID: 9831541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin E increases biomarkers of estrogen stimulation when taken with tamoxifen.
    Peralta EA; Brewer AT; Louis S; Dunnington GL
    J Surg Res; 2009 May; 153(1):143-7. PubMed ID: 18468636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyridoxal supplementation reduces cell proliferation and DNA synthesis in estrogen-dependent and -independent mammary carcinoma cell lines.
    Davis BA; Cowing BE
    Nutr Cancer; 2000; 38(2):281-6. PubMed ID: 11525607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alteration of α-tocopherol-associated protein (TAP) expression in human breast epithelial cells during breast cancer development.
    Tam KW; Ho CT; Lee WJ; Tu SH; Huang CS; Chen CS; Lee CH; Wu CH; Ho YS
    Food Chem; 2013 Jun; 138(2-3):1015-21. PubMed ID: 23411208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of LDL oxidation on the proliferation of human breast cancer cells.
    Chajes V; Mahon M; Kostner GM
    Free Radic Biol Med; 1996; 20(1):113-20. PubMed ID: 8903687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice.
    Du M; Yang X; Hartman JA; Cooke PS; Doerge DR; Ju YH; Helferich WG
    Carcinogenesis; 2012 Apr; 33(4):895-901. PubMed ID: 22266527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide YY and vitamin E inhibit hormone-sensitive and -insensitive breast cancer cells.
    Heisler T; Towfigh S; Simon N; McFadden DW
    J Surg Res; 2000 Jun; 91(1):9-14. PubMed ID: 10816343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin E stimulates proliferation of experimental oral carcinoma cells in vitro.
    Odukoya O; Schwartz J; Shklar G
    Nutr Cancer; 1986; 8(2):101-6. PubMed ID: 3703685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.